Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $293.61 -0.57%
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: -30.7%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $486.3 million versus the consensus estimate of $492.35 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- CareDx completes $171.2M sale of lab products unit to Eurobio Scientific
- Summit Hotel Properties refinances $650M credit facility through 2031
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
